Daewoong Pharma

Price Chart

Risk-Adjusted Performance

Daewoong Pharma (069620) Price Performance

Daewoong Pharma (069620) trades on KO in KRW. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at KRW150400.00, up 1.97% from the previous close.

Over the past year, 069620 has traded between a low of KRW129200.00 and a high of KRW194000.00. The stock has gained 13.7% over this period. It is currently 22.5% below its 52-week high.

Daewoong Pharma has a market capitalization of $1.68T, with a price-to-earnings ratio of 8.58 and a dividend yield of 0.40%.

About Daewoong Pharma

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.